Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ibrahim H. Ozercan"'
Autor:
Kazim Sahin, Cemal Orhan, Osman Kucuk, Mehmet Tuzcu, Nurhan Sahin, Ibrahim H. Ozercan, Sarah Sylla, Sara P. Ojalvo, James R. Komorowski
Publikováno v:
Food Chemistry: Molecular Sciences, Vol 4, Iss , Pp 100081- (2022)
This study aimed to examine the impacts of the magnesium picolinate (MgPic), zinc picolinate (ZnPic), and selenomethionine (SeMet) alone or as a combination on blood metabolites, oxidative enzymes, reproductive hormones, and glucose and lipid metabol
Externí odkaz:
https://doaj.org/article/2eede4fbdd02411b8ee40d6aa37429d8
Autor:
Fatih M. Uckun, Cemal Orhan, Mehmet Tuzcu, Ali Said Durmus, Ibrahim H. Ozercan, Michael Volk, Kazim Sahin
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundWe recently reported the clinical safety profile of RJX, a well-defined intravenous GMP-grade pharmaceutical formulation of anti-oxidant and anti-inflammatory vitamins as active ingredients, in a Phase 1 study in healthy volunteers (Clinica
Externí odkaz:
https://doaj.org/article/d5d71df53e5645eda6a2339ec55cb731
Autor:
F. Selcuk Simsek, Muharrem Cakmak, Duygu Kuslu, Tansel A. Balci, Erdal In, Ibrahim H. Ozercan, Yavuz Narin
Publikováno v:
Archives of Medical Science, Vol 19, Iss 2, Pp 385-391 (2021)
Introduction There is no consensus about the standardized uptake value maximum (SUV max ) cut-off value to characterize pleural thickening worldwide. Sometimes, this causes unnecessary invasive diagnostic procedures. Our first aim is to determine a c
Externí odkaz:
https://doaj.org/article/cb9fa89c3a65470a9d2f316ed13dee16
Autor:
Fatih M. Uckun, Cemal Orhan, Joy Powell, Emre Sahin, Ibrahim H. Ozercan, Michael Volk, Kazim Sahin
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 141, Iss , Pp 111823- (2021)
Here, we demonstrate that the two distinct formulations of our anti-sepsis drug candidate Rejuveinix (RJX), have a very favorable safety profile in Wistar Albino rats at dose levels comparable to the projected clinical dose levels. 14-day treatment w
Externí odkaz:
https://doaj.org/article/672581214b4b4751a3b6497f0705bd56
Autor:
Fatih M. Uckun, James Carlson, Cemal Orhan, Joy Powell, Natalie M. Pizzimenti, Hendrik van Wyk, Ibrahim H. Ozercan, Michael Volk, Kazim Sahin
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Background: New treatment platforms that can prevent acute respiratory distress syndrome (ARDS) or reduce its mortality rate in high-risk coronavirus disease 2019 (COVID-19) patients, such as those with an underlying cancer, are urgently needed. Reju
Externí odkaz:
https://doaj.org/article/25dd179769cd4dcbaeae5886f7dbe74e
Autor:
Fatih M Uckun, Muhammad Saeed, Mustafa Awili, Ibrahim H Ozercan, Sanjive Qazi, Cynthia Lee, Adeel Shibli, Alan W Skolnick, Alonso Prusmack, Joseph Varon, Cesar IP Barrera, Cemal Orhan, Michael Volk, Kazim Sahin
Publikováno v:
Future Microbiology. 17:1217-1229
Aim: Our main objectives were to compare the effects of Rejuveinix (RJX), dexamethasone (DEX) and their combination on the severity of sepsis and survival outcome in an animal model of fatal sepsis. Methods: We used the LPS plus D-galactosamine mouse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e560a410019f67eca3276e8a61f85a
https://doi.org/10.2217/fmb-2022-0044
https://doi.org/10.2217/fmb-2022-0044
Autor:
Omer Kucuk, Bulent Ozpolat, Nashwa Kabil, Ibrahim H. Ozercan, Nurhan Sahin, Mehmet Tuzcu, Cemal Orhan, Birdal Bilir, Engin Yenice, Kazim Sahin
Genistein, the major isoflavone in soybean, has been reported to exert anticancer effects on various types of cancer including ovarian cancer; however, its chemopreventive effects and mechanisms of action in ovarian cancer have not been fully elucida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b032ef517ee09a732f7d350391961124
https://doi.org/10.1158/1940-6207.c.6547469.v1
https://doi.org/10.1158/1940-6207.c.6547469.v1
Autor:
Omer Kucuk, Bulent Ozpolat, Nashwa Kabil, Ibrahim H. Ozercan, Nurhan Sahin, Mehmet Tuzcu, Cemal Orhan, Birdal Bilir, Engin Yenice, Kazim Sahin
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124527b4f53be83c2291a21596beeb55
https://doi.org/10.1158/1940-6207.22534364.v1
https://doi.org/10.1158/1940-6207.22534364.v1
Autor:
Fatih M. Uckun, Muhammad Saeed, Mustafa Awili, Ibrahim H. Ozercan, Sanjive Qazi, Cynthia Lee, Adeel Shibli, Alan W. Skolnick, Alonso Prusmack, Joseph Varon, Cesar I.P. Barrera, Cemal Orhan, Michael Volk, Kazim Sahin
BackgroundThe identification of effective strategies capable of reducing the case mortality rate of high-risk COVID-19 is an urgent and unmet medical need. We recently reported the clinical safety profile of RJX, a well-defined intravenous GMP-grade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7553271c8244ab1c0c048c0b1a12402
https://doi.org/10.1101/2022.02.12.22270748
https://doi.org/10.1101/2022.02.12.22270748
Publikováno v:
Surgery Today; May2004, Vol. 34 Issue 5, p470-472, 181p